Medical News today, Aug. 20, 2018.
The U.N. Food and Drug Administration (FDA) has banned the use of the popular drug Eliminoglutethimide (EG), one of the main anti-inflammatory agents used to treat asthma.
The agency said in a statement today that it had ordered its European counterparts to ban the drug as well, citing the risk of side effects.
Eliminoglurt is a combination of two ingredients: a glycoside of glycerol, or sugar, and one that contains insulin, a hormone that can slow the release of the enzyme glucose from the pancreas.
Both ingredients are found in a variety of medical products, including cough syrups, inhalers and nasal sprays.EG is a drug that is used to improve breathing by slowing down the flow of air through the airways, which can help reduce inflammation.
Eg is a major class of drugs used to prevent allergic reactions and treat conditions including asthma, diabetes, cardiovascular diseases, and certain cancers.
It is used in about 40% of U.K. adults and more than 70% of adults in the United States.
But the FDA says EG is not approved for use in adults because of the high risk of toxicity.
In a statement, the agency said it had decided to ban use of EG in the country as a result of the adverse side effects of using it for a short period of time.
It said the drug can cause severe side effects including: dizziness, trouble breathing, difficulty swallowing, nausea, vomiting, abdominal pain, skin rashes, joint pain, headaches, anxiety and insomnia.
The FDA said it will issue additional guidance on the drug’s use in the coming weeks, but said the agency will allow people to use EG if they have a doctor’s approval.